ArticleScientific reports2026
Preliminary quantitative assessment of liver and spleen MR imaging and elastography in clinically significant portal hypertension.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Patients with clinically significant portal hypertension (CSPH) are at high risk of developing severe complications of portal hypertension. The aim of our preliminary study was to assess multiparametric liver and spleen MRI and MR elastography for the estimation of CSPH. Seventy-eight patients with advanced chronic liver disease and hepatic venous pressure gradient measurements, who had liver and spleen MRI and MR elastography were assessed. Liver and spleen elasticity and viscosity maps with texture features were derived from the MR elastography acquisitions. Liver surface nodularity (LSN) and texture features were obtained from the T2-weighted MR images. Features were analyzed with regularized generalized canonical correlation analysis for dimensionality reduction. Models based on the combination of MRI and MR elastography features were trained and evaluated, using a support vector machine classifier. Forty-eight patients (62%) had CSPH. Most models based on hepatic and/or splenic MR elastography features, T2 texture features or LSN had fair performance (AUCs 0.7–0.79) for CSPH diagnosis. Multiparametric models that included MR elastography features and LSN had good diagnostic performance (AUCs 0.8–0.89), without improvement with the addition of T2 texture features. Our results suggest that combining liver and spleen MR elastography features with LSN may produce efficient models for diagnosing CSPH.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.